SCICLONE PHARMACEUTICALS INC Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SCICLONE PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SCICLONE PHARMACEUTICALS INC for March 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 30 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 2.49 | 9,160 | 22,808 | 499,160 | |
Mar 30 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 2.49 | 840 | 2,092 | 508,320 | |
Mar 30 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.29 | 9,160 | 85,076 | 205,252 | 214.4 K to 205.3 K (-4.27 %) |
Mar 30 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 2.49 | 9,160 | 22,808 | 214,412 | 205.3 K to 214.4 K (+4.46 %) |
Mar 30 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.29 | 840 | 7,802 | 205,252 | 206.1 K to 205.3 K (-0.41 %) |
Mar 30 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 2.49 | 840 | 2,092 | 206,092 | 205.3 K to 206.1 K (+0.41 %) |
Mar 21 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 2.49 | 10,000 | 24,900 | 509,160 | |
Mar 21 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.09 | 10,000 | 90,936 | 205,252 | 215.3 K to 205.3 K (-4.65 %) |
Mar 21 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 2.49 | 10,000 | 24,900 | 215,252 | 205.3 K to 215.3 K (+4.87 %) |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | King Robert | SVP of Prod Devp/ S ... | Option Exercise | A | 0.00 | 7,000 | 0 | 15,000 | |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | King Robert | SVP of Prod Devp/ S ... | Option Exercise | A | 9.12 | 38,362 | 349,861 | 38,362 | |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | King Robert | SVP of Prod Devp/ S ... | Option Exercise | A | 9.12 | 10,638 | 97,019 | 10,638 | |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | A | 0.00 | 12,000 | 0 | 174,000 | |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | A | 9.12 | 84,000 | 766,080 | 84,000 | |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | A | 0.00 | 4,000 | 0 | 8,000 | |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | A | 9.12 | 28,000 | 255,360 | 28,000 | |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | A | 0.00 | 5,000 | 0 | 10,000 | |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | A | 9.12 | 19,077 | 173,982 | 19,077 | |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | A | 9.12 | 15,923 | 145,218 | 15,923 | |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | A | 0.00 | 20,000 | 0 | 343,500 | |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | A | 9.12 | 128,757 | 1,174,264 | 128,757 | |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | A | 9.12 | 11,243 | 102,536 | 11,243 | |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | A | 0.00 | 12,000 | 0 | 199,000 | |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | A | 9.12 | 72,869 | 664,565 | 72,869 | |
Mar 17 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | A | 9.12 | 11,131 | 101,515 | 11,131 | |
Mar 08 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 2.49 | 2,406 | 5,991 | 519,160 | |
Mar 08 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 2.49 | 17,594 | 43,809 | 521,566 | |
Mar 08 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.00 | 2,406 | 24,060 | 205,252 | 207.7 K to 205.3 K (-1.16 %) |
Mar 08 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 2.49 | 2,406 | 5,991 | 207,658 | 205.3 K to 207.7 K (+1.17 %) |
Mar 08 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.01 | 17,594 | 176,046 | 205,252 | 222.8 K to 205.3 K (-7.90 %) |
Mar 08 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 2.49 | 17,594 | 43,809 | 222,846 | 205.3 K to 222.8 K (+8.57 %) |
Mar 01 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 2.49 | 10,000 | 24,900 | 539,160 | |
Mar 01 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.98 | 10,000 | 99,771 | 204,252 | 214.3 K to 204.3 K (-4.67 %) |
Mar 01 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 2.49 | 10,000 | 24,900 | 214,252 | 204.3 K to 214.3 K (+4.90 %) |